Video Experimental Relacionado

Updated: Jan 7, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Un marco lógico general para las terapias de cáncer de CAR-T y nanocarrier

Patrick Rehorst¹, Alexander Kros¹

¹Supramolecular and Biomaterials Chemistry, , Leiden Institute of Chemistry, Leiden University, Leiden, Einsteinweg 55, 2333 CC Leiden, The Netherlands.

Journal of controlled release : official journal of the Controlled Release Society

|January 1, 2026

Resumen

No abstract available in PubMed .

Palabras clave:

Terapia con células CAR-T Terapias basadas en la lógica Orientación por múltiples marcadores Entrega de fármacos basados en nanoportadores Toxicidad en el objetivo y fuera del tumor El microambiente del tumor

Más Videos Relacionados

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Videos de Conceptos Relacionados

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...